microRNA 21-mediated suppression of sprouty1 by Pokemon affects liver cancer cell growth and proliferation

Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the re...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular biochemistry Vol. 114; no. 7; pp. 1625 - 1633
Main Authors Jin, Xiu-Li, Sun, Qin-Sheng, Liu, Feng, Yang, Hong-Wei, Liu, Min, Liu, Hong-Xia, Xu, Wei, Jiang, Yu-Yang
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR‐21‐mediated regulatory circuit. In normal (HL‐7702) and cancer (QGY‐7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA‐mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR‐21 and interestingly, we found that miR‐21 is up‐regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up‐regulated miR‐21 transcription in a dose‐dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR‐21 promoter at −747 to −399 bp. Site‐directed mutagenesis of the GC boxes at −684 to −679 bp and −652 to −647 bp of miR‐21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR‐21 expression affected the growth and proliferation of liver cancer cells QGY‐7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR‐21‐mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR‐21 and Sprouty1 as novel targets of the Pokemon regulatory network. J. Cell. Biochem. 114: 1625–1633, 2013. © 2013 Wiley Periodicals, Inc.
AbstractList Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399bp. Site-directed mutagenesis of the GC boxes at -684 to -679bp and -652 to -647bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network. J. Cell. Biochem. 114: 1625-1633, 2013. © 2013 Wiley Periodicals, Inc. [PUBLICATION ABSTRACT]
Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR‐21‐mediated regulatory circuit. In normal (HL‐7702) and cancer (QGY‐7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA‐mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR‐21 and interestingly, we found that miR‐21 is up‐regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up‐regulated miR‐21 transcription in a dose‐dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR‐21 promoter at −747 to −399 bp. Site‐directed mutagenesis of the GC boxes at −684 to −679 bp and −652 to −647 bp of miR‐21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR‐21 expression affected the growth and proliferation of liver cancer cells QGY‐7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR‐21‐mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR‐21 and Sprouty1 as novel targets of the Pokemon regulatory network. J. Cell. Biochem. 114: 1625–1633, 2013. © 2013 Wiley Periodicals, Inc.
Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399 bp. Site-directed mutagenesis of the GC boxes at -684 to -679 bp and -652 to -647 bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network.Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399 bp. Site-directed mutagenesis of the GC boxes at -684 to -679 bp and -652 to -647 bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network.
Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an oncogene. Oncomine database suggests a potential correlation between the expressions of Pokemon and Sprouty1. This study investigated the regulatory role of Pokemon in Sprouty1 expression and the effect on liver cancer cell growth and proliferation, revealing a novel miR-21-mediated regulatory circuit. In normal (HL-7702) and cancer (QGY-7703) liver cell lines, Sprouty1 expression is inversely correlated with Pokemon levels. Targeted expression or siRNA-mediated silencing showed that Pokemon is a repressor of Sprouty1 expression at both mRNA and protein levels, but Pokemon cannot affect the promoter activity of Sprouty1. Sprouty1 is a target of miR-21 and interestingly, we found that miR-21 is up-regulated by Pokemon in liver cancer cells. Luciferase reporter assays showed that Pokemon up-regulated miR-21 transcription in a dose-dependent manner, and ChIP assay exhibited a direct binding of Pokemon to the miR-21 promoter at -747 to -399 bp. Site-directed mutagenesis of the GC boxes at -684 to -679 bp and -652 to -647 bp of miR-21 promoter abolished the regulatory activity by Pokemon. Furthermore, we found that the modulation of Pokemon and miR-21 expression affected the growth and proliferation of liver cancer cells QGY-7703. In summary, our findings demonstrate that Pokemon suppresses Sprouty1 expression through a miR-21-mediated mechanism, affecting the growth and proliferation of liver cancer cells. This study recognized miR-21 and Sprouty1 as novel targets of the Pokemon regulatory network.
Author Yang, Hong-Wei
Sun, Qin-Sheng
Liu, Feng
Jiang, Yu-Yang
Liu, Hong-Xia
Jin, Xiu-Li
Liu, Min
Xu, Wei
Author_xml – sequence: 1
  givenname: Xiu-Li
  surname: Jin
  fullname: Jin, Xiu-Li
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
– sequence: 2
  givenname: Qin-Sheng
  surname: Sun
  fullname: Sun, Qin-Sheng
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
– sequence: 3
  givenname: Feng
  surname: Liu
  fullname: Liu, Feng
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
– sequence: 4
  givenname: Hong-Wei
  surname: Yang
  fullname: Yang, Hong-Wei
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
– sequence: 5
  givenname: Min
  surname: Liu
  fullname: Liu, Min
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
– sequence: 6
  givenname: Hong-Xia
  surname: Liu
  fullname: Liu, Hong-Xia
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
– sequence: 7
  givenname: Wei
  surname: Xu
  fullname: Xu, Wei
  email: shxuwei8720@163.com
  organization: School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
– sequence: 8
  givenname: Yu-Yang
  surname: Jiang
  fullname: Jiang, Yu-Yang
  email: jiangyy@sz.tsinghua.edu.cn
  organization: The State Key Laboratory Breeding Base-Shenzhen Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P. R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23355454$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtvEzEUhS1URNPCgj-ALLGhi2n9drwsKTSgUCoe6tLyONfgdDIT7JmW_HucJmFRwepK1neO7z3nCB20XQsIvaTklBLCzha-PmVCEvEEjSgxuhJKiAM0IpqTinHKDtFRzgtCiDGcPUOHjHMphRQjtFhGn7ovV-eY0WoJ8-h6mOM8rFYJco5di7uA8yp1Q7-muF7j6-4WluXZhQC-z7iJd5Cwd63fDGga_CN19_1P7No5LromBkiuL07P0dPgmgwvdvMYfX__7ttkWs0-X36YnM8qzw0VlXLGkHHN5pRz5nmQpq61ckpwo3jQLgimvR-DVAASAtXaK10HXkvKRS0dP0Zvtr7l918D5N4uY95s5lrohmwpl2RshKLjgr5-hC66IbVlu0IJo3XJSBXq1Y4a6hKRXaW4dGlt9ykW4GwLlChzThCsj_3DzX1ysbGU2E1PtvRkH3oqipNHir3pv9id-31sYP1_0H6cvN0rqq0i5h5-_1W4dGuV5lram6tLez39Orv4dDG1N_wPtKuv8g
CitedBy_id crossref_primary_10_1016_j_jconrel_2015_08_009
crossref_primary_10_1155_2013_804128
crossref_primary_10_1016_j_nano_2019_102063
crossref_primary_10_1089_rej_2016_1829
crossref_primary_10_1016_j_bbrep_2021_101026
crossref_primary_10_1002_ddr_21270
crossref_primary_10_7314_APJCP_2013_14_11_6315
crossref_primary_10_1007_s12072_015_9697_y
crossref_primary_10_2217_pgs_13_143
crossref_primary_10_1016_S1665_2681_19_31165_2
crossref_primary_10_1007_s11033_021_06405_x
crossref_primary_10_1002_mc_22542
crossref_primary_10_1080_16078454_2021_2010330
crossref_primary_10_1186_s40246_019_0252_0
crossref_primary_10_1016_j_smim_2015_11_006
crossref_primary_10_1038_s41419_020_2585_y
crossref_primary_10_1186_1757_2215_7_61
crossref_primary_10_1159_000440790
crossref_primary_10_1002_jcb_26077
crossref_primary_10_1007_s13277_015_3744_0
crossref_primary_10_1016_j_bbrc_2024_150888
crossref_primary_10_1016_j_biopha_2016_12_122
crossref_primary_10_1186_s12859_020_03732_x
crossref_primary_10_3390_ijms17050735
crossref_primary_10_1007_s13277_015_3596_7
crossref_primary_10_1016_j_semcancer_2017_02_001
Cites_doi 10.1158/0008-5472.CAN-05-1072
10.1074/jbc.M802935200
10.1016/j.yexmp.2010.05.002
10.1038/nrm1644
10.1093/nar/27.5.1251
10.1038/nature03552
10.1371/journal.pone.0002542
10.1038/nature07511
10.1158/0008-5472.CAN-04-1207
10.1158/0008-5472.CAN-07-1936
10.1158/0008-5472.CAN-05-1055
10.1038/sj.onc.1202332
10.1073/pnas.0510565103
10.1074/jbc.M611393200
10.1038/sj.onc.1210856
10.1182/blood.V94.6.1987
10.1242/dev.126.11.2515
10.1186/1756-0500-2-175
10.4049/jimmunol.176.4.2414
10.1016/j.cell.2009.01.002
10.1128/MCB.17.7.3786
10.1016/j.cell.2005.10.043
10.1016/S0092-8674(00)80919-8
10.1038/sj.onc.1210083
10.1016/S0092-8674(00)80576-0
10.1038/ng1077
10.1152/physiolgenomics.00085.2009
10.1242/dev.126.18.4139
10.1016/j.bbrc.2006.09.167
10.1158/0008-5472.CAN-03-3759
10.1053/j.gastro.2007.05.022
10.1186/bcr2843
10.1074/jbc.M110.114736
10.1093/nar/gkn712
10.1091/mbc.E08-02-0159
10.1371/journal.pcbi.0030131
10.1080/10428190902763517
10.1016/j.ccr.2010.08.013
10.1002/path.2222
10.1158/0008-5472.CAN-05-0137
10.1016/S0092-8674(04)00045-5
10.1038/nature03203
ContentType Journal Article
Copyright Copyright © 2013 Wiley Periodicals, Inc.
Copyright_xml – notice: Copyright © 2013 Wiley Periodicals, Inc.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1002/jcb.24504
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
CrossRef
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1097-4644
EndPage 1633
ExternalDocumentID 2966587671
23355454
10_1002_jcb_24504
JCB24504
ark_67375_WNG_PHSLDMDH_W
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: The Ministry of Science and Technology of China
  funderid: 2012ZX09506001‐010; 2012CB722605; 2012AA020305; 2011DFA30620
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH6
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NDZJH
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RBB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V8K
W8V
W99
WBKPD
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WSB
WXSBR
WYISQ
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c3914-6a9908b2d1332c3f59bb76a643963f7af427cc8e56ee5ef177c67bf3b5134b5a3
IEDL.DBID DR2
ISSN 0730-2312
1097-4644
IngestDate Fri Jul 11 01:13:54 EDT 2025
Sun Jul 13 04:47:06 EDT 2025
Mon Jul 21 06:03:26 EDT 2025
Tue Jul 01 03:55:52 EDT 2025
Thu Apr 24 22:57:47 EDT 2025
Wed Jan 22 16:20:28 EST 2025
Wed Oct 30 09:52:17 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
Copyright © 2013 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3914-6a9908b2d1332c3f59bb76a643963f7af427cc8e56ee5ef177c67bf3b5134b5a3
Notes istex:EE503DB1CF0A65A5D367381355ACF15205682824
ark:/67375/WNG-PHSLDMDH-W
Conflict of interest: nothing to declare.
ArticleID:JCB24504
The Ministry of Science and Technology of China - No. 2012ZX09506001-010; No. 2012CB722605; No. 2012AA020305; No. 2011DFA30620
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 23355454
PQID 1349774546
PQPubID 1006368
PageCount 9
ParticipantIDs proquest_miscellaneous_1350894618
proquest_journals_1349774546
pubmed_primary_23355454
crossref_citationtrail_10_1002_jcb_24504
crossref_primary_10_1002_jcb_24504
wiley_primary_10_1002_jcb_24504_JCB24504
istex_primary_ark_67375_WNG_PHSLDMDH_W
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-07
July 2013
2013-07-00
2013-Jul
20130701
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: United States
PublicationTitle Journal of cellular biochemistry
PublicationTitleAlternate J. Cell. Biochem
PublicationYear 2013
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley Subscription Services, Inc
References Apostolopoulou K, Pateras I, Evangelou K, Tsantoulis P, Liontos M, Kittas C, Tiniakos D, Kotsinas A, Cordon-Cardo C, Gorgoulis V. 2007. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213:294-302.
Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y. 2011. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res 13:R26.
Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029.
Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA. 2006. Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J Immunol 176:2414.
Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y. 2006. miR-21-mediated tumor growth. Oncogene 26:2799-2803.
Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984.
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-22261.
Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M. 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19:3272-3282.
Shalgi R, Lieber D, Oren M, Pilpel Y. 2007. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3:e131.
Fong CW, Chua MS, McKie AB, Ling SHM, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SKS. 2006. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 66:2048.
Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658.
Reich A, Sapir A, Shilo B. 1999. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126:4139.
Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33:197-202.
Zu X, Yu L, Sun Q, Liu F, Wang J, Xie Z, Wang Y, Xu W, Jiang Y. 2009. SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells. BMC Res Notes 2:175.
Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, Hernandez N. 1999. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 27:1251.
Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233.
Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S, Allgayer H. 2007. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136.
Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y. 1999. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126:2515-2525.
Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. 2004. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64:4728.
Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
Yu X, Lin J, Zack DJ, Mendell JT, Qian J. 2008. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res 36:6494-6503.
Pessler F, Pendergrast PS, Hernandez N. 1997. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17:3786.
Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. 2009. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50:506-509.
Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu YT, Weng Z. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219.
Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O. 1999. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94:1987-1997.
Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92:253-263.
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ. 2005. A microRNA polycistron as a potential human oncogene. Nature 435:828-833.
Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. 2005a. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433:278-285.
Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ESM, Leong HF, Zeng Q. 2004. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 64:6127-6136.
Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: Implications for senescence. PLoS ONE 3:e2542.
Kim VN. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385.
Schubot FD, Tropea JE, Waugh DS. 2006. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 351:1-6.
Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW. 2008. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283:33199-33210.
Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699.
Maeda T, Hobbs RM, Pandolfi PP. 2005b. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res 65:8575.
Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L. 2010. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem 285:39551.
Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E, Olson EN. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18:282-293.
Aggarwal A, Hunter WJ III, Aggarwal H, Silva ED, Davey MS, Murphy RF, Agrawal DK. 2010. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol 89:140-148.
Davies J, Hawe N, Kabarowski J, Huang Q, Zhu J, Brand N, Leprince D, Dhordain P, Cook M, Morriss-Kay G. 1999. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18:365.
Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, Mariani L, Cremisi F, Rainaldi G. 2009. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics 39:210-218.
Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328.
Casci T, Vinós J, Freeman M. 1999. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96:655-665.
2004; 64
2007; 282
2010; 18
1999; 27
2008; 19
2005; 435
2008; 36
2006; 176
2005; 65
2006; 351
2010; 285
2011; 13
2005a; 433
2008; 3
1999; 126
2009; 136
2008; 283
2003; 33
2010; 89
2007; 213
2004; 116
2009; 50
1999; 18
2006; 66
2007; 133
2006; 26
2005b; 65
1997; 17
2005; 6
1998; 92
1999; 96
2008; 456
1999; 94
2007; 3
2009; 2
2007; 67
2006; 103
2007; 27
2009; 39
2006; 124
e_1_2_5_27_1
e_1_2_5_28_1
e_1_2_5_25_1
e_1_2_5_26_1
e_1_2_5_23_1
e_1_2_5_24_1
e_1_2_5_21_1
e_1_2_5_22_1
e_1_2_5_43_1
e_1_2_5_29_1
e_1_2_5_42_1
e_1_2_5_41_1
e_1_2_5_40_1
e_1_2_5_15_1
e_1_2_5_38_1
e_1_2_5_14_1
e_1_2_5_39_1
e_1_2_5_17_1
e_1_2_5_36_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_37_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_34_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_35_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_32_1
e_1_2_5_5_1
e_1_2_5_12_1
Kukita A (e_1_2_5_20_1) 1999; 94
e_1_2_5_33_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
e_1_2_5_30_1
e_1_2_5_31_1
References_xml – reference: Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233.
– reference: Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW. 2008. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283:33199-33210.
– reference: Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, Hernandez N. 1999. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 27:1251.
– reference: Reich A, Sapir A, Shilo B. 1999. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126:4139.
– reference: Davies J, Hawe N, Kabarowski J, Huang Q, Zhu J, Brand N, Leprince D, Dhordain P, Cook M, Morriss-Kay G. 1999. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18:365.
– reference: Schubot FD, Tropea JE, Waugh DS. 2006. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 351:1-6.
– reference: Kim VN. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385.
– reference: Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
– reference: Apostolopoulou K, Pateras I, Evangelou K, Tsantoulis P, Liontos M, Kittas C, Tiniakos D, Kotsinas A, Cordon-Cardo C, Gorgoulis V. 2007. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213:294-302.
– reference: Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029.
– reference: Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA. 2006. Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J Immunol 176:2414.
– reference: Maeda T, Hobbs RM, Pandolfi PP. 2005b. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res 65:8575.
– reference: Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y. 2006. miR-21-mediated tumor growth. Oncogene 26:2799-2803.
– reference: Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. 2004. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64:4728.
– reference: Zu X, Yu L, Sun Q, Liu F, Wang J, Xie Z, Wang Y, Xu W, Jiang Y. 2009. SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells. BMC Res Notes 2:175.
– reference: Aggarwal A, Hunter WJ III, Aggarwal H, Silva ED, Davey MS, Murphy RF, Agrawal DK. 2010. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol 89:140-148.
– reference: Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L. 2010. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem 285:39551.
– reference: Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y. 2011. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res 13:R26.
– reference: Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92:253-263.
– reference: Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658.
– reference: Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: Implications for senescence. PLoS ONE 3:e2542.
– reference: Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M. 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19:3272-3282.
– reference: Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984.
– reference: Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-22261.
– reference: Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328.
– reference: Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, Mariani L, Cremisi F, Rainaldi G. 2009. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics 39:210-218.
– reference: Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E, Olson EN. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18:282-293.
– reference: Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O. 1999. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94:1987-1997.
– reference: Fong CW, Chua MS, McKie AB, Ling SHM, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SKS. 2006. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 66:2048.
– reference: Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. 2009. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50:506-509.
– reference: Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S, Allgayer H. 2007. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136.
– reference: Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ESM, Leong HF, Zeng Q. 2004. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 64:6127-6136.
– reference: Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y. 1999. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126:2515-2525.
– reference: He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ. 2005. A microRNA polycistron as a potential human oncogene. Nature 435:828-833.
– reference: Yu X, Lin J, Zack DJ, Mendell JT, Qian J. 2008. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res 36:6494-6503.
– reference: Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu YT, Weng Z. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219.
– reference: Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33:197-202.
– reference: Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699.
– reference: Casci T, Vinós J, Freeman M. 1999. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96:655-665.
– reference: Pessler F, Pendergrast PS, Hernandez N. 1997. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17:3786.
– reference: Shalgi R, Lieber D, Oren M, Pilpel Y. 2007. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3:e131.
– reference: Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. 2005a. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433:278-285.
– volume: 103
  start-page: 2257
  year: 2006
  end-page: 22261
  article-title: A microRNA expression signature of human solid tumors defines cancer gene targets
  publication-title: Proc Natl Acad Sci USA
– volume: 116
  start-page: 281
  year: 2004
  end-page: 297
  article-title: MicroRNAs: Genomics, biogenesis, mechanism, and function
  publication-title: Cell
– volume: 6
  start-page: 376
  year: 2005
  end-page: 385
  article-title: MicroRNA biogenesis: Coordinated cropping and dicing
  publication-title: Nat Rev Mol Cell Biol
– volume: 64
  start-page: 6127
  year: 2004
  end-page: 6136
  article-title: The ras/mitogen‐activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer
  publication-title: Cancer Res
– volume: 433
  start-page: 278
  year: 2005a
  end-page: 285
  article-title: Role of the proto‐oncogene Pokemon in cellular transformation and ARF repression
  publication-title: Nature
– volume: 2
  start-page: 175
  year: 2009
  article-title: SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells
  publication-title: BMC Res Notes
– volume: 39
  start-page: 210
  year: 2009
  end-page: 218
  article-title: miR‐290 acts as a physiological effector of senescence in mouse embryo fibroblasts
  publication-title: Physiol Genomics
– volume: 3
  start-page: e2542
  year: 2008
  article-title: The proto‐oncogene LRF is under post‐transcriptional control of MiR‐20a: Implications for senescence
  publication-title: PLoS ONE
– volume: 64
  start-page: 4728
  year: 2004
  article-title: The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer
  publication-title: Cancer Res
– volume: 65
  start-page: 8575
  year: 2005b
  article-title: The transcription factor Pokemon: A new key player in cancer pathogenesis
  publication-title: Cancer Res
– volume: 283
  start-page: 33199
  year: 2008
  end-page: 33210
  article-title: Proto‐oncogene FBI‐1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co‐repressors
  publication-title: J Biol Chem
– volume: 36
  start-page: 6494
  year: 2008
  end-page: 6503
  article-title: Analysis of regulatory network topology reveals functionally distinct classes of microRNAs
  publication-title: Nucleic Acids Res
– volume: 17
  start-page: 3786
  year: 1997
  article-title: Purification and characterization of FBI‐1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts
  publication-title: Mol Cell Biol
– volume: 33
  start-page: 197
  year: 2003
  end-page: 202
  article-title: Heterozygous disruption of Hic1 predisposes mice to a gender‐dependent spectrum of malignant tumors
  publication-title: Nat Genet
– volume: 18
  start-page: 365
  year: 1999
  article-title: Novel BTB/POZ domain zinc‐finger protein, LRF, is a potential target of the LAZ‐3/BCL‐6 oncogene
  publication-title: Oncogene
– volume: 89
  start-page: 140
  year: 2010
  end-page: 148
  article-title: Expression of leukemia/lymphoma‐related factor (LRF/POKEMON) in human breast carcinoma and other cancers
  publication-title: Exp Mol Pathol
– volume: 19
  start-page: 3272
  year: 2008
  end-page: 3282
  article-title: MicroRNA‐21 targets Sprouty2 and promotes cellular outgrowths
  publication-title: Mol Biol Cell
– volume: 126
  start-page: 4139
  year: 1999
  article-title: Sprouty is a general inhibitor of receptor tyrosine kinase signaling
  publication-title: Development
– volume: 26
  start-page: 2799
  year: 2006
  end-page: 2803
  article-title: miR‐21‐mediated tumor growth
  publication-title: Oncogene
– volume: 435
  start-page: 828
  year: 2005
  end-page: 833
  article-title: A microRNA polycistron as a potential human oncogene
  publication-title: Nature
– volume: 213
  start-page: 294
  year: 2007
  end-page: 302
  article-title: Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non‐small cell lung cancer
  publication-title: J Pathol
– volume: 124
  start-page: 207
  year: 2006
  end-page: 219
  article-title: A global map of p53 transcription‐factor binding sites in the human genome
  publication-title: Cell
– volume: 67
  start-page: 8699
  year: 2007
  article-title: MicroRNA signatures in human ovarian cancer
  publication-title: Cancer Res
– volume: 456
  start-page: 980
  year: 2008
  end-page: 984
  article-title: MicroRNA‐21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
  publication-title: Nature
– volume: 27
  start-page: 1251
  year: 1999
  article-title: FBI‐1, a factor that binds to the HIV‐1 inducer of short transcripts (IST), is a POZ domain protein
  publication-title: Nucleic Acids Res
– volume: 282
  start-page: 14328
  year: 2007
  article-title: MicroRNA‐21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
  publication-title: J Biol Chem
– volume: 176
  start-page: 2414
  year: 2006
  article-title: Endotoxin‐induced down‐regulation of Elk‐3 facilitates heme oxygenase‐1 induction in macrophages
  publication-title: J Immunol
– volume: 18
  start-page: 282
  year: 2010
  end-page: 293
  article-title: Modulation of K‐Ras‐dependent lung tumorigenesis by MicroRNA‐21
  publication-title: Cancer Cell
– volume: 94
  start-page: 1987
  year: 1999
  end-page: 1997
  article-title: Osteoclast‐derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis
  publication-title: Blood
– volume: 285
  start-page: 39551
  year: 2010
  article-title: MicroRNA (miRNA)‐mediated interaction between leukemia/lymphoma‐related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis
  publication-title: J Biol Chem
– volume: 96
  start-page: 655
  year: 1999
  end-page: 665
  article-title: Sprouty, an intracellular inhibitor of Ras signaling
  publication-title: Cell
– volume: 50
  start-page: 506
  year: 2009
  end-page: 509
  article-title: MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes
  publication-title: Leuk Lymphoma
– volume: 126
  start-page: 2515
  year: 1999
  end-page: 2525
  article-title: Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila
  publication-title: Development
– volume: 92
  start-page: 253
  year: 1998
  end-page: 263
  article-title: sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways
  publication-title: Cell
– volume: 27
  start-page: 2128
  year: 2007
  end-page: 2136
  article-title: MicroRNA‐21 (miR‐21) post‐transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
  publication-title: Oncogene
– volume: 3
  start-page: e131
  year: 2007
  article-title: Global and local architecture of the mammalian microRNA‐transcription factor regulatory network
  publication-title: PLoS Comput Biol
– volume: 133
  start-page: 647
  year: 2007
  end-page: 658
  article-title: MicroRNA‐21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
  publication-title: Gastroenterology
– volume: 66
  start-page: 2048
  year: 2006
  article-title: Sprouty 2, an inhibitor of mitogen‐activated protein kinase signaling, is down‐regulated in hepatocellular carcinoma
  publication-title: Cancer Res
– volume: 65
  start-page: 6029
  year: 2005
  article-title: MicroRNA‐21 is an antiapoptotic factor in human glioblastoma cells
  publication-title: Cancer Res
– volume: 351
  start-page: 1
  year: 2006
  end-page: 6
  article-title: Structure of the POZ domain of human LRF, a master regulator of oncogenesis
  publication-title: Biochem Biophys Res Commun
– volume: 136
  start-page: 215
  year: 2009
  end-page: 233
  article-title: MicroRNAs: Target recognition and regulatory functions
  publication-title: Cell
– volume: 13
  start-page: R26
  year: 2011
  article-title: Pro‐oncogene Pokemon promotes breast cancer progression by upregulating survivin expression
  publication-title: Breast Cancer Res
– ident: e_1_2_5_12_1
  doi: 10.1158/0008-5472.CAN-05-1072
– ident: e_1_2_5_17_1
  doi: 10.1074/jbc.M802935200
– ident: e_1_2_5_2_1
  doi: 10.1016/j.yexmp.2010.05.002
– ident: e_1_2_5_18_1
  doi: 10.1038/nrm1644
– ident: e_1_2_5_26_1
  doi: 10.1093/nar/27.5.1251
– ident: e_1_2_5_15_1
  doi: 10.1038/nature03552
– ident: e_1_2_5_30_1
  doi: 10.1371/journal.pone.0002542
– ident: e_1_2_5_36_1
  doi: 10.1038/nature07511
– ident: e_1_2_5_22_1
  doi: 10.1158/0008-5472.CAN-04-1207
– ident: e_1_2_5_16_1
  doi: 10.1158/0008-5472.CAN-07-1936
– ident: e_1_2_5_24_1
  doi: 10.1158/0008-5472.CAN-05-1055
– ident: e_1_2_5_11_1
  doi: 10.1038/sj.onc.1202332
– ident: e_1_2_5_38_1
  doi: 10.1073/pnas.0510565103
– ident: e_1_2_5_41_1
  doi: 10.1074/jbc.M611393200
– ident: e_1_2_5_4_1
  doi: 10.1038/sj.onc.1210856
– volume: 94
  start-page: 1987
  year: 1999
  ident: e_1_2_5_20_1
  article-title: Osteoclast‐derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis
  publication-title: Blood
  doi: 10.1182/blood.V94.6.1987
– ident: e_1_2_5_19_1
  doi: 10.1242/dev.126.11.2515
– ident: e_1_2_5_42_1
  doi: 10.1186/1756-0500-2-175
– ident: e_1_2_5_10_1
  doi: 10.4049/jimmunol.176.4.2414
– ident: e_1_2_5_6_1
  doi: 10.1016/j.cell.2009.01.002
– ident: e_1_2_5_28_1
  doi: 10.1128/MCB.17.7.3786
– ident: e_1_2_5_39_1
  doi: 10.1016/j.cell.2005.10.043
– ident: e_1_2_5_13_1
  doi: 10.1016/S0092-8674(00)80919-8
– ident: e_1_2_5_35_1
  doi: 10.1038/sj.onc.1210083
– ident: e_1_2_5_7_1
  doi: 10.1016/S0092-8674(00)80576-0
– ident: e_1_2_5_9_1
  doi: 10.1038/ng1077
– ident: e_1_2_5_29_1
  doi: 10.1152/physiolgenomics.00085.2009
– ident: e_1_2_5_31_1
  doi: 10.1242/dev.126.18.4139
– ident: e_1_2_5_33_1
  doi: 10.1016/j.bbrc.2006.09.167
– ident: e_1_2_5_21_1
  doi: 10.1158/0008-5472.CAN-03-3759
– ident: e_1_2_5_25_1
  doi: 10.1053/j.gastro.2007.05.022
– ident: e_1_2_5_43_1
  doi: 10.1186/bcr2843
– ident: e_1_2_5_37_1
  doi: 10.1074/jbc.M110.114736
– ident: e_1_2_5_40_1
  doi: 10.1093/nar/gkn712
– ident: e_1_2_5_32_1
  doi: 10.1091/mbc.E08-02-0159
– ident: e_1_2_5_34_1
  doi: 10.1371/journal.pcbi.0030131
– ident: e_1_2_5_27_1
  doi: 10.1080/10428190902763517
– ident: e_1_2_5_14_1
  doi: 10.1016/j.ccr.2010.08.013
– ident: e_1_2_5_3_1
  doi: 10.1002/path.2222
– ident: e_1_2_5_8_1
  doi: 10.1158/0008-5472.CAN-05-0137
– ident: e_1_2_5_5_1
  doi: 10.1016/S0092-8674(04)00045-5
– ident: e_1_2_5_23_1
  doi: 10.1038/nature03203
SSID ssj0009932
Score 2.2388926
Snippet Transcriptional repressor Pokemon is a critical factor in embryogenesis, development, cell proliferation, differentiation, and oncogenesis, thus behaving as an...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1625
SubjectTerms Adaptor Proteins, Signal Transducing
Blotting, Western
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - metabolism
Cell Proliferation
Chromatin Immunoprecipitation
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
Embryonic growth stage
Gene Expression Regulation, Neoplastic - genetics
Gene Expression Regulation, Neoplastic - physiology
Humans
LIVER CANCER
Liver Neoplasms - genetics
Liver Neoplasms - metabolism
Membrane Proteins - genetics
Membrane Proteins - metabolism
microRNA 21
MicroRNAs - genetics
MicroRNAs - metabolism
Mutagenesis, Site-Directed
Phosphoproteins - genetics
Phosphoproteins - metabolism
POKEMON
Promoter Regions, Genetic - genetics
Real-Time Polymerase Chain Reaction
siRNA
Sprouty1
Transcription Factors - genetics
Transcription Factors - metabolism
Title microRNA 21-mediated suppression of sprouty1 by Pokemon affects liver cancer cell growth and proliferation
URI https://api.istex.fr/ark:/67375/WNG-PHSLDMDH-W/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.24504
https://www.ncbi.nlm.nih.gov/pubmed/23355454
https://www.proquest.com/docview/1349774546
https://www.proquest.com/docview/1350894618
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB5KRfTFS71Fq4wi0pdsN3NN8KlurUuxS6mW9kEYZiYzlm5Mlt0Nuj75E_yN_hJnJpdSqSA-JZATMjnznZwvyZnvAPBymFNrTZrHQ6XTmNDExKnFSaxdNleZRpiH3oAHEzY-Jvun9HQNvO7WwjT6EP0HNx8Z4XntA1yqxfaFaOi5VgNEaNAC9bVanhAdXUhHubwb_iA4BMeOw6BOVWiItvszL-Wia96t364impd5a0g8e7fBp27ITb3JdFAv1UB__0PN8T_v6Q641RJSuNMg6C5YM-UGuN60qFxtgBujriPcPVB88dV7R5MdiJJfP36GRSeOsMJFPWvLaUtYWbhwQ62XqwSqFTyspsYBHcqmbAQWvgwEag81tzFFAT_Pq6_LMyjLHM58ByFrGkzeB8d7bz-OxnHbrSHWOEtIzKRLbKlCuXvrRRpbminFmfSMh2HLpSWIa50ayoyhxiaca8aVxYommCgq8QOwXlaleQRgRnCe58QS967qCCVLmbKI82FYRqsyGYGtbt6EbqXMfUeNQjQizEg4R4rgyAi86E1njX7HVUavwuT3FnI-9QVvnIqTyTtxOP7wfvdgdyxOIrDZoUO0sb4QXuDRkWhKWASe94fd1HgvytJUtbdxRDgjLEkj8LBBVX8xhD3no24UWwEbfx-n2B-9CTuP_930CbiJQgcPX2G8CdaX89o8dTxqqZ6FgPkNBeAXUA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VVqhceJTXQgGDAPWSbeLYeRw4lF1K2u6uqtKqvZnYsUHskqz2obKc-An8EP4Kf4Jfgu08qqIicemBUyJllDieGc83yfgbgOduRpWSUea4XEQOoZ50IuV7jtDRnMcC-6HtDdgfBMkR2T2hJ0vwo94LU_JDNB_cjGfY9do4uPkgvXnGGvpJ8DYm1CVVSeWeXJzqhG36aqertfsC4-03h53EqXoKOMKPPeIEqV5-I44znZth4Ssacx4GqYnLga_CVBEcChFJGkhJpfLCUAQhVz6nnk84TX193yuwYjqIG6b-7sEZWZWO9PafhfYZR6MmXPMYuXizGeq56LdiFPnlImh7HinbULd9A37Wk1RWuAzb8xlvi69_8Ef-L7N4E65XmBttlU5yC5ZkvgZXyy6cizVY7dRN727D6LMpUDwYbCHs_fr23e6r0ZgcTefjqmI4R4VCUz0389nCQ3yB9ouh1L6M0rIyBo1MpQsSxpv0QY5G6MOkOJ19RGmeobFpkqRk6XZ34OhSXvsuLOdFLu8DiomfZRlRRKfjGjMHUcAVDkPX7hTmcdqCjdpQmKjY2k3TkBEreaYx04pjVnEteNaIjkuKkouEXlprayTSydDU9IWUHQ_esv3kXa_b7ybsuAXrtTmyajmbMsNhqfMESoIWPG0ua9WYWUxzWcyNjMb6MQm8qAX3SjNuHoZ9A2upHsWGNca_j5Ptdl7bkwf_LvoEVpPDfo_1dgZ7D-Eatg1LTEH1OizPJnP5SMPGGX9svRXB-8s27N_T2HTG
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VVjwuPMproYBBgHrJNnFsJzlwKLss29dq1VK1NxM7Nohdsqt9qCwnfgL_g7_Cr-CXYDuPqqhIXHrglEgZJY5nxvNNMv4G4LmfUa1VnHm-kLFHaKC8WIeBJ000F4nEYeR6A-71WPeQbB_T4yX4Ue2FKfgh6g9u1jPcem0dfJzpjVPS0E9SNDGhPikrKnfU4sTka9NXW22j3BcYd968a3W9sqWAJ8MkIB5LzeobC5yZ1AzLUNNEiIilNiyzUEepJjiSMlaUKUWVDqJIskjoUNAgJIKmobnvJVghzE9sn4j2_ilXlQn07peFcRnPgCZc0Rj5eKMe6pngt2L1-OU8ZHsWKLtI17kBP6s5KgpcBs35TDTl1z_oI_-TSbwJ10vEjTYLF7kFSypfhctFD87FKlxtVS3vbsPwsy1P3O9tIhz8-vbd7aoxiBxN5-OyXjhHI42mZmrms0WAxAL1RwNlPBmlRV0MGto6FyStL5mDGg7Rh8noZPYRpXmGxrZFklaF092Bwwt57buwnI9ydR9QQsIsy4gmJhk3iJnFTGgcRb7bJyyStAHrlZ1wWXK125YhQ16wTGNuFMed4hrwrBYdFwQl5wm9dMZWS6STga3oiyg_6r3l_e7Bbnuv3eVHDVirrJGXi9mUWwZLkyVQwhrwtL5sVGNnMc3VaG5lDNJPCAviBtwrrLh-GA4tqKVmFOvOFv8-Tr7deu1OHvy76BO40m93-O5Wb-chXMOuW4mtpl6D5dlkrh4ZzDgTj52vInh_0Xb9G-lxc3U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=microRNA+21-mediated+suppression+of+Sprouty1+by+Pokemon+affects+liver+cancer+cell+growth+and+proliferation&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Jin%2C+Xiu-Li&rft.au=Sun%2C+Qin-Sheng&rft.au=Liu%2C+Feng&rft.au=Yang%2C+Hong-Wei&rft.date=2013-07-01&rft.eissn=1097-4644&rft.volume=114&rft.issue=7&rft.spage=1625&rft_id=info:doi/10.1002%2Fjcb.24504&rft_id=info%3Apmid%2F23355454&rft.externalDocID=23355454
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon